A Clinically Applicable Conversion Formula Between NT-proBNP and BNP in Light-Chain Amyloidosis. [PDF]
Muchtar E +9 more
europepmc +1 more source
Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials. [PDF]
Wechalekar AD +18 more
europepmc +1 more source
Pulmonary coexistence of immunoglobulin light chain amyloidosis and light chain deposition disease: A case report. [PDF]
Murakami Y +10 more
europepmc +1 more source
Two Decades of Light-Chain Amyloidosis: Real-World Trends in Diagnosis, Treatment, and Survival. [PDF]
Gorecki G +7 more
europepmc +1 more source
A Case of Amyloid Light-Chain Amyloidosis Presenting as Colitis. [PDF]
Prabakaran K +7 more
europepmc +1 more source
Cardiac Biomarker Complete Response in Light Chain Amyloidosis: How Much of the Heart Is Captured? [PDF]
Gunn AH, Chase CC, Khouri MG.
europepmc +1 more source
Amyloid light-chain amyloidosis with cardiac failure: a case description and literature analysis. [PDF]
Liu L, Lyu Y, Zhao S.
europepmc +1 more source
Technetium Pyrophosphate Blood Pool Uptake Mistaken for Myocardial Uptake in Light-Chain Amyloidosis: A Dangerous Misinterpretation. [PDF]
Falk RH.
europepmc +1 more source
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases. [PDF]
Carpinteiro A +15 more
europepmc +1 more source
Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients. [PDF]
Song L +9 more
europepmc +1 more source

